Meritage Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,074,120
| Closed | -$198M | – | 20 |
|
|
2024
Q4 | $198M | Sell |
1,074,120
-111,047
| -9% | -$20.5M | 4.73% | 11 |
|
|
2024
Q3 | $233M | Buy |
1,185,167
+2,510
| +0.2% | +$494K | 5.45% | 9 |
|
|
2024
Q2 | $244M | Buy |
1,182,657
+389
| +0% | +$80.4K | 6.21% | 10 |
|
|
2024
Q1 | $320M | Buy |
1,182,268
+26,892
| +2% | +$7.29M | 7.54% | 4 |
|
|
2023
Q4 | $273M | Buy |
1,155,376
+271,743
| +31% | +$64.2M | 6.29% | 9 |
|
|
2023
Q3 | $173M | Buy |
+883,633
| New | +$173M | 4.11% | 13 |
|